Novel insights into TB vaccines and diagnostics

In this webinar, we'll showcase how to use FluoroSpot and ELISpot for immune characterization in the context of tuberculosis. Discover how to optimize these assays for your TB vaccine research and diagnostics.

Subjects include

• Cecilia Lindestam Arlehamn's work on a peptide pool distinguishing patients with active disease from latent infection
• Christopher Sundling's work on using FluoroSpot for evaluating novel biomarkers
• ELISpot and FluoroSpot assay optimization
• And more!

Our presenter and panelists

• Cecilia Lindestam Arlehamn, PhD, Research Assistant Professor, La Jolla Institute for Immunology (https://www.lji.org/labs/lindestam-arlehamn-lab/)
• Christopher Sundling, PhD, Principal Researcher, Karolinska Institutet (https://ki.se/en/meds/team-christopher-sundling)
• Jens Gertow, PhD, Chief Commercial Officer, Mabtech AB (www.mabtech.com)

The presentation is followed by a Q&A session with our panelists.